• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腹腔镜胰腺手术联合肝动脉切除与重建的单中心初步经验

A single-center initial experience on laparoscopic pancreatic operation combined with hepatic arterial resection and reconstruction.

作者信息

Xu Jie, Wang Jia-Guo, Lei Kai, Liu Zuo-Jin

机构信息

Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.

出版信息

Front Surg. 2023 May 17;10:1153531. doi: 10.3389/fsurg.2023.1153531. eCollection 2023.

DOI:10.3389/fsurg.2023.1153531
PMID:37266002
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10229900/
Abstract

OBJECTIVE

This study aims to summarize our single-center initial experience in laparoscopic pancreatic operation (LPO) combined with hepatic arterial resection and reconstruction, as well as to demonstrate the feasibility, safety, and key surgical procedure for LPO.

METHODS

We retrospectively analyzed 7 patients who had undergone LPO combined with hepatic arterial resection and reconstruction in our center from January 2021 to December 2022. The clinical data of these 7 patients were collected and analyzed.

RESULTS

In our case series, two patients underwent passive arterial resection and reconstruction due to iatrogenic arterial injury, and five patients underwent forward arterial resection and reconstruction due to arterial invasion. The arterial anastomosis was successful in 5 cases, including 2 cases of end-to-end and 3 cases of arterial transposition, and the vascular reconstruction time was 38.28 ± 15.32 min. There were two conversions to laparotomy. The postoperative recovery of all patients was uneventful, with one liver abscess (Segment 4) and no Clavien III-IV complications. We also share valuable technical feedback and experience gained from the initial practice.

CONCLUSIONS

Based on the surgeon's proficiency in open arterial resection and reconstruction and laparoscopic technique. This study demonstrated the feasibility of total laparoscopic hepatic arterial resection and reconstruction in properly selected cases of arterial involvement or iatrogenic arterial injury. Our initial experience provides valuable information for laparoscopic pancreas surgery with arterial resection and reconstruction.

摘要

目的

本研究旨在总结我们单中心在腹腔镜胰腺手术(LPO)联合肝动脉切除与重建方面的初步经验,并展示LPO的可行性、安全性及关键手术步骤。

方法

我们回顾性分析了2021年1月至2022年12月在本中心接受LPO联合肝动脉切除与重建的7例患者。收集并分析了这7例患者的临床资料。

结果

在我们的病例系列中,2例因医源性动脉损伤接受了被动动脉切除与重建,5例因动脉侵犯接受了主动动脉切除与重建。动脉吻合成功5例,包括2例端端吻合和3例动脉转位,血管重建时间为38.28±15.32分钟。有2例中转开腹。所有患者术后恢复顺利,出现1例肝脓肿(第4段),无Clavien III-IV级并发症。我们还分享了从最初实践中获得的宝贵技术反馈和经验。

结论

基于外科医生在开放动脉切除与重建及腹腔镜技术方面的熟练程度。本研究证明了在适当选择的动脉受累或医源性动脉损伤病例中,全腹腔镜肝动脉切除与重建的可行性。我们的初步经验为腹腔镜胰腺手术联合动脉切除与重建提供了有价值的信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5229/10229900/2a4ee1f1e100/fsurg-10-1153531-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5229/10229900/80a4d66bda43/fsurg-10-1153531-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5229/10229900/2a4ee1f1e100/fsurg-10-1153531-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5229/10229900/80a4d66bda43/fsurg-10-1153531-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5229/10229900/2a4ee1f1e100/fsurg-10-1153531-g002.jpg

相似文献

1
A single-center initial experience on laparoscopic pancreatic operation combined with hepatic arterial resection and reconstruction.腹腔镜胰腺手术联合肝动脉切除与重建的单中心初步经验
Front Surg. 2023 May 17;10:1153531. doi: 10.3389/fsurg.2023.1153531. eCollection 2023.
2
Preliminary experience on laparoscopic pancreaticoduodenal combined with major venous resection and reconstruction anastomosis.腹腔镜胰十二指肠切除术联合主要静脉切除与重建吻合术的初步经验
Front Surg. 2022 Sep 8;9:974214. doi: 10.3389/fsurg.2022.974214. eCollection 2022.
3
[Real-world data analysis of 3012 patients undergoing laparoscopic radical gastrectomy in a single center over the past 12 years].[对过去12年在单一中心接受腹腔镜根治性胃切除术的3012例患者的真实世界数据分析]
Zhonghua Wei Chang Wai Ke Za Zhi. 2022 Aug 25;25(8):716-725. doi: 10.3760/cma.j.cn441530-20220613-00257.
4
[Preliminary experience with double-tract reconstruction combined with π-shaped esophagojejunal anastomosis after total laparoscopic proximal gastrectomy for the treatment of adenocarcinoma of esophagogastric junction].全腹腔镜近端胃切除治疗食管胃交界腺癌双通路重建联合π形食管空肠吻合术的初步经验
Zhonghua Wei Chang Wai Ke Za Zhi. 2022 May 25;25(5):440-446. doi: 10.3760/cma.j.cn441530-20210812-00327.
5
Efficacy and safety of laparoscopic radical resection following neoadjuvant therapy for pancreatic ductal adenocarcinoma: A retrospective study.新辅助治疗后腹腔镜根治性切除术治疗胰腺导管腺癌的疗效与安全性:一项回顾性研究
World J Gastrointest Oncol. 2022 Sep 15;14(9):1785-1797. doi: 10.4251/wjgo.v14.i9.1785.
6
Strategic Approach to Aberrant Hepatic Arterial Anatomy during Laparoscopic Pancreaticoduodenectomy: Technique with Video.腹腔镜胰十二指肠切除术中肝动脉解剖变异的策略性处理:附视频技术
J Clin Med. 2023 Mar 1;12(5):1965. doi: 10.3390/jcm12051965.
7
[The clinical impact of artery-first approach combined with vascular resection and reconstruction in the treatment of pancreatic head carcinoma].[动脉优先入路联合血管切除重建在胰头癌治疗中的临床影响]
Zhonghua Zhong Liu Za Zhi. 2017 Mar 23;39(3):225-230. doi: 10.3760/cma.j.issn.0253-3766.2017.03.014.
8
Arterial resection and reconstruction in pancreatectomy: surgical technique and outcomes.胰十二指肠切除术中的动脉切除与重建:手术技术与结果
BMC Surg. 2019 Oct 10;19(1):141. doi: 10.1186/s12893-019-0560-2.
9
[Analysis of short-term efficacy of overlapping delta-shaped anastomosis in totally laparoscopic left hemicolectomy for digestive tract reconstruction].[完全腹腔镜下左半结肠切除术消化道重建中重叠三角吻合术的短期疗效分析]
Zhonghua Wei Chang Wai Ke Za Zhi. 2021 May 25;24(5):433-439. doi: 10.3760/cma.j.cn.441530-20200505-00255.
10
[Two Cases of Laparoscopic Pancreaticoduodenectomy in the Sophisticated and Complicated Situations (with Video)].复杂情况下的两例腹腔镜胰十二指肠切除术(附视频)
Sichuan Da Xue Xue Bao Yi Xue Ban. 2020 Jul;51(4):457-461. doi: 10.12182/20200760501.

本文引用的文献

1
Tips and tricks for robotic pancreatoduodenectomy with superior mesenteric/portal vein resection and reconstruction.机器人胰十二指肠切除术伴肠系膜上/门静脉切除与重建的技巧。
Surg Endosc. 2023 Apr;37(4):3233-3245. doi: 10.1007/s00464-022-09860-0. Epub 2023 Jan 9.
2
A phase II study of gemcitabine/nab-paclitaxel/S-1 combination neoadjuvant chemotherapy for patients with borderline resectable pancreatic cancer with arterial contact.吉西他滨/白蛋白紫杉醇/S-1 联合新辅助化疗治疗伴动脉侵犯的局部可切除胰腺癌的 II 期研究。
Eur J Cancer. 2021 Dec;159:215-223. doi: 10.1016/j.ejca.2021.10.012. Epub 2021 Nov 12.
3
Laparoscopic versus open pancreatoduodenectomy for pancreatic or periampullary tumours: a multicentre, open-label, randomised controlled trial.
腹腔镜与开腹胰十二指肠切除术治疗胰腺或壶腹周围肿瘤:一项多中心、开放标签、随机对照试验。
Lancet Gastroenterol Hepatol. 2021 Jun;6(6):438-447. doi: 10.1016/S2468-1253(21)00054-6. Epub 2021 Apr 27.
4
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
5
Arterial Resection in Pancreatic Cancer Surgery: Effective After a Learning Curve.胰腺癌手术中的动脉切除:度过学习曲线后效果显著。
Ann Surg. 2022 Apr 1;275(4):759-768. doi: 10.1097/SLA.0000000000004054.
6
An anatomical review of various superior mesenteric artery-first approaches during pancreatoduodenectomy for pancreatic cancer.对胰腺癌胰十二指肠切除术中各种肠系膜上动脉优先入路的解剖学复习。
Surg Today. 2021 Jun;51(6):872-879. doi: 10.1007/s00595-020-02150-z. Epub 2020 Sep 22.
7
Arterial resection during pancreatectomy for pancreatic ductal adenocarcinoma with arterial invasion: A single-center experience with 109 patients.胰腺癌伴动脉侵犯行胰十二指肠切除术中的动脉切除:109例患者的单中心经验
Medicine (Baltimore). 2020 Sep 11;99(37):e22115. doi: 10.1097/MD.0000000000022115.
8
3D-laparoscopic pancreaticoduodenectomy with superior mesenteric or portal vein resection for pancreatic cancer.3D 腹腔镜胰十二指肠切除术联合肠系膜上静脉或门静脉切除治疗胰腺癌。
Surg Endosc. 2020 Dec;34(12):5616-5624. doi: 10.1007/s00464-020-07847-3. Epub 2020 Aug 4.
9
Neoadjuvant modified FOLFIRINOX followed by postoperative gemcitabine in borderline resectable pancreatic adenocarcinoma: a Phase 2 study for clinical and biomarker analysis.新辅助改良 FOLFIRINOX 方案治疗边界可切除胰腺腺癌后行 gemcitabine 辅助化疗:一项用于临床和生物标志物分析的 2 期研究。
Br J Cancer. 2020 Aug;123(3):362-368. doi: 10.1038/s41416-020-0867-x. Epub 2020 May 20.
10
Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-Analysis.新辅助 FOLFIRINOX 方案在边界可切除胰腺癌患者中的应用:系统评价和患者水平的荟萃分析。
J Natl Cancer Inst. 2019 Aug 1;111(8):782-794. doi: 10.1093/jnci/djz073.